Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors

por Schrock, Alexa B, Madison, Russell, Rosenzweig, Mark, Allen, Justin M, Erlich, Rachel L, Wang, Siao-Yi, Chidiac, Tarek, Reddy, Vodur Suresh, Riess, Jonathan W, Yassa, Ahmet Ersin, Shakir, Abdur, Miller, Vincent A, Alexander, Brian M, Venstrom, Jeffrey, McGregor, Kimberly, Ali, Siraj M
Publicado 2020